Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.
about
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskMolecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsHigher Immunological Protection of Pandemic 2009 H1N1 Influenza Live Virus Infection than Split Vaccine Against the Homologous Virus for Long Term Immunization in Ferret.Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusCharacterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B VirusesAssociation between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virusReduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaquesAbsence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets.Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)The first influenza pandemic of the new millennium.Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: influence of prior seasonal influenza vaccination.Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines.Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 seasonAn eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.Fc receptors in antibody-dependent enhancement of viral infections.Pathogenic analysis of the pandemic 2009 H1N1 influenza A viruses in ferrets.Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.Development and Regulation of Novel Influenza Virus Vaccines: A United States Young Scientist Perspective.Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenza.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.
P2860
Q27330166-417AC7F2-FE42-475A-B0C3-C818AB3DF30EQ28236770-B66F5795-06A5-4B91-ABA6-0DA1DB5F9137Q28474889-F7CAECCC-F6D7-4BB2-A698-F08AE4F4F4FFQ30356268-53E77C0F-2C06-4EBC-AC70-65F14FE20BCAQ30360439-0761AD99-42C0-48EF-9F03-21288208DE54Q30383049-D0746383-63CA-4855-AD1C-131F566EC823Q30388012-D0020478-615E-49C7-BEA9-C94F3B5F7D0AQ30391443-172CC273-4491-4E37-A4B6-2A4FA5F4DB50Q30392198-74F70D54-053B-4995-984F-38BA2FA54B8CQ30395259-71901DFD-EA3B-4254-A2F4-E6CDED6159F9Q30396348-BA0A4774-74AF-443F-93F2-26EE04E87C33Q30397104-6D0CDB68-F1CD-46A7-95E8-B0B0799EB724Q30398068-1288B0A0-DD17-4986-B638-7DA7B142FF5FQ30398879-3CF3362D-538B-47E0-A886-540C1055E707Q30398916-D5F673D2-041B-43EC-9E30-97557DC00AC6Q30401658-532C4606-D721-42D9-B1E1-3CA961003404Q30402300-8B22FCFA-C2A5-447C-B78C-928BABF88368Q30405211-576027FB-29D2-465C-A189-C94AD0E7E4FDQ30407081-4688A03D-A73C-49D3-A3BB-DCB3BAD10C38Q30426547-C7F98473-C241-4198-8522-326407EAB677Q31088337-69E271E1-9FD9-4D3C-B0FE-5D02BFC503BAQ34614814-6DA745E2-84D0-4979-A953-DF01C94408C7Q37123091-3B9AC952-30E1-4338-9C3A-095CA31CEE26Q38615396-CC1AE4F2-D65B-4A81-9E90-3979B58DC230Q40136115-C529EE26-71E0-4F57-98F3-49A9D7237753Q47555103-4224A8C0-B9FD-41C8-8D26-241AF707EA97Q52558438-099B6B53-EA1B-4C47-82E9-5FF30B07161CQ55397256-4BBB2161-F679-4994-AA5E-D9725875F792Q55554478-311DCFE1-8934-495D-938B-2C8E5DE49BB3
P2860
Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@ast
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@en
type
label
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@ast
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@en
prefLabel
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@ast
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@en
P2093
P356
P1476
Assessment of the efficacy of ...... st a pandemic H1N1 2009 virus.
@en
P2093
Anders Leung
Isabelle Meunier
James L Neufeld
Jason Gren
Shane Stebner
Stéphane Pillet
Veronika von Messling
P304
P356
10.1086/651171
P407
P577
2010-04-01T00:00:00Z